GGT5
Basic information
Region (hg38): 22:24219654-24245108
Previous symbols: [ "GGTLA1" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GGT5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 71 | 76 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 71 | 5 | 3 |
Variants in GGT5
This is a list of pathogenic ClinVar variants found in the GGT5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
22-24219983-G-A | not specified | Uncertain significance (Aug 14, 2023) | ||
22-24220007-G-A | not specified | Uncertain significance (Jan 21, 2025) | ||
22-24220011-C-T | not specified | Uncertain significance (May 03, 2023) | ||
22-24220041-C-T | not specified | Uncertain significance (Apr 27, 2024) | ||
22-24220065-A-C | not specified | Uncertain significance (May 31, 2023) | ||
22-24220114-C-G | not specified | Uncertain significance (Oct 01, 2024) | ||
22-24225006-T-C | not specified | Likely benign (Mar 31, 2023) | ||
22-24225032-G-C | not specified | Uncertain significance (Jun 29, 2023) | ||
22-24225055-C-T | not specified | Uncertain significance (Jul 11, 2023) | ||
22-24225066-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
22-24225069-C-T | not specified | Uncertain significance (Jan 23, 2023) | ||
22-24225086-C-A | not specified | Uncertain significance (Aug 14, 2024) | ||
22-24225106-C-T | not specified | Uncertain significance (Oct 25, 2022) | ||
22-24225346-G-A | not specified | Uncertain significance (Dec 03, 2021) | ||
22-24225351-C-T | not specified | Uncertain significance (May 11, 2022) | ||
22-24225369-G-A | not specified | Uncertain significance (Jan 22, 2025) | ||
22-24225381-C-G | not specified | Uncertain significance (Nov 11, 2024) | ||
22-24225396-A-C | Likely benign (Mar 01, 2023) | |||
22-24225564-C-T | not specified | Uncertain significance (May 01, 2024) | ||
22-24225572-C-T | Benign (Jan 30, 2018) | |||
22-24225584-T-G | not specified | Uncertain significance (Mar 20, 2024) | ||
22-24225585-C-T | not specified | Uncertain significance (Jul 19, 2023) | ||
22-24225618-T-C | not specified | Uncertain significance (Sep 25, 2024) | ||
22-24225620-C-A | not specified | Uncertain significance (Oct 29, 2024) | ||
22-24226103-A-C | not specified | Uncertain significance (Mar 29, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GGT5 | protein_coding | protein_coding | ENST00000398292 | 12 | 25489 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.16e-11 | 0.409 | 125688 | 0 | 59 | 125747 | 0.000235 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.690 | 315 | 351 | 0.896 | 0.0000215 | 3661 |
Missense in Polyphen | 123 | 155.74 | 0.78978 | 1672 | ||
Synonymous | -1.34 | 184 | 162 | 1.13 | 0.0000110 | 1268 |
Loss of Function | 1.16 | 20 | 26.5 | 0.756 | 0.00000158 | 256 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000654 | 0.000644 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000277 | 0.000272 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.000285 | 0.000264 |
Middle Eastern | 0.000277 | 0.000272 |
South Asian | 0.000367 | 0.000359 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Cleaves the gamma-glutamyl peptide bond of glutathione conjugates, but maybe not glutathione itself. Converts leukotriene C4 (LTC4) to leukotriene D4 (LTD4).;
- Pathway
- Glutathione metabolism - Homo sapiens (human);Arachidonic acid metabolism - Homo sapiens (human);Taurine and hypotaurine metabolism - Homo sapiens (human);Glutathione metabolism;Glutathione conjugation;Metabolism of lipids;Phase II - Conjugation of compounds;Prostaglandin Leukotriene metabolism;Synthesis of Leukotrienes (LT) and Eoxins (EX);Arachidonic acid metabolism;Biological oxidations;Metabolism;Fatty acid metabolism;Glutathione synthesis and recycling;Aflatoxin activation and detoxification
(Consensus)
Intolerance Scores
- loftool
- 0.822
- rvis_EVS
- -0.37
- rvis_percentile_EVS
- 28.2
Haploinsufficiency Scores
- pHI
- 0.0504
- hipred
- N
- hipred_score
- 0.199
- ghis
- 0.477
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.432
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ggt5
- Phenotype
- growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); immune system phenotype; pigmentation phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); vision/eye phenotype;
Gene ontology
- Biological process
- translation;proteolysis;cellular amino acid metabolic process;glutamate metabolic process;fatty acid metabolic process;leukotriene metabolic process;glutathione metabolic process;glutathione biosynthetic process;glutathione catabolic process;inflammatory response;cysteine biosynthetic process;leukotriene D4 biosynthetic process
- Cellular component
- plasma membrane;integral component of membrane;intrinsic component of plasma membrane
- Molecular function
- peptidyltransferase activity;leukotriene-C(4) hydrolase;glutathione hydrolase activity;hypoglycin A gamma-glutamyl transpeptidase activity;leukotriene C4 gamma-glutamyl transferase activity